Welcome!
Raffles Medical Group (RMG)
Zest
Raffles Hospital partners South Korea-based Myongji Hospital to offer 'travel medicine pass'
With this, pass holders can access medical services and a seamless booking of the pre-departure and on-arrival Covid-19 testing.
December 13, 2021
Broker's Calls
Broker's Digest: CapitaLand Investment, SATS, Singtel, Raffles Medical Group, MNACT
See what the analysts have to say about these counters.
October 15, 2021
Broker's Calls
DBS raises Raffles Medical Group's TP to $1.81, estimates FY2022-2023 earnings could hit record high
As at 3.57pm, shares in Raffles Medical are trading 2 cents higher or 1.31% up at $1.55.
October 14, 2021
Broker's Calls
RHB pushes target price on Raffles Medical to $1.65 following news of further reopening of Singapore's borders
“Our new target price implies 2022F P/E of 39x, which is in line with the P/E multiple for regional (ASEAN) healthcare operators"
October 11, 2021
Broker's Calls
Imminent reopening of borders brings opportunities for Raffles Medical : RHB
RHB Group Research is maintaining its ‘buy’ call and target price of $1.45 on Raffles Medical, at a 4% upside
September 21, 2021
Broker's Calls
Analysts mixed on Raffles Medical even as it appears immunised to the Covid-19 bug
The group’s PATMI of $39.4 million beat expectations of analysts from RHB and CGS-CIMB.
July 27, 2021
Results
Raffles Medical posts 128.7% surge in 1H2021 earnings; expects to be more profitable this year
Earnings of healthcare provider Raffles Medical Group surged by 128.7% to $39.4 million for 1HFY2021 ended June
July 26, 2021
Broker's Calls
'Buy' Raffles Medical, as it benefits from Singapore's reopening: analysts
Jaiswal is maintaining his “buy” call on the company at a revised target price of $1.35.
July 13, 2021
Deals, joint ventures & alliances
Raffles Medical Group and China Life Healthcare embark on strategic partnership to support ageing populations
China Life Healthcare is a subsidiary of China Life Insurance (Group).
June 01, 2021